Find Clinical Trial

Efficacy on systolic and diastolic blood pressure decrease and safety of once-a-day oral 5 mg Perindopril arginine salt (titrated to 10 mg). A 12-week, 2-arm, randomised, double-blind study versus once-a-day oral 4 mg perindopril tert-butylamine salt (titrated to 2 x 4 mg) in hypertensive patients.


← Back
Study Phase

Phase 3

Therapeutic Area

Cardiovascular Diseases

IndicationHypertension
SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active substance/
Medical device

PERINDOPRIL ARGININE,
S006490

Active Substance CodeS006490
Protocol CodeCL3-06490-003


Documents and links

Results summary READ MORE
Scientific publication READ MORE




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2022 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility